Boespflug EL, Iliff JJ (2018) The Emerging Relationship Between Interstitial Fluid-Cerebrospinal Fluid Exchange, Amyloid-beta, and Sleep. Biological psychiatry 83 (4):328-336. doi:10.1016/j.biopsych.2017.11.031
Brown BM, Rainey-Smith SR, Bucks RS, Weinborn M, Martins RN (2016) Exploring the bi-directional relationship between sleep and beta-amyloid. Current opinion in psychiatry 29 (6):397-401. doi:10.1097/YCO.0000000000000285
Burdakov D (2019) Reactive and predictive homeostasis: Roles of orexin/hypocretin neurons. Neuropharmacology 154:61-67. doi:10.1016/j.neuropharm.2018.10.024
Cheng SB, Kuchiiwa S, Gao HZ, Kuchiiwa T, Nakagawa S (2003) Morphological study of orexin neurons in the hypothalamus of the Long-Evans rat, with special reference to co-expression of orexin and NADPH-diaphorase or nitric oxide synthase activities. Neuroscience research 46 (1):53-62. doi:10.1016/s0168-0102(03)00026-9
Cousins JN, Van Rijn E, Ong JL, Chee MWL (2019) A split sleep schedule rescues short-term topographical memory after multiple nights of sleep restriction. Sleep 42 (4). doi:10.1093/sleep/zsz018
Dauvilliers YA, Lehmann S, Jaussent I, Gabelle A (2014) Hypocretin and brain beta-amyloid peptide interactions in cognitive disorders and narcolepsy. Frontiers in aging neuroscience 6:119. doi:10.3389/fnagi.2014.00119
Dey A, Bhattacharya R, Mukherjee A, Pandey DK (2017) Natural products against Alzheimer's disease: Pharmaco-therapeutics and biotechnological interventions. Biotechnology advances 35 (2):178-216. doi:10.1016/j.biotechadv.2016.12.005
Facchinetti R, Bronzuoli MR, Scuderi C (2018) An Animal Model of Alzheimer Disease Based on the Intrahippocampal Injection of Amyloid beta-Peptide (1-42). Methods in molecular biology 1727:343-352. doi:10.1007/978-1-4939-7571-6_25
Fronczek R, van Geest S, Frolich M, Overeem S, Roelandse FW, Lammers GJ, Swaab DF (2012) Hypocretin (orexin) loss in Alzheimer's disease. Neurobiology of aging 33 (8):1642-1650. doi:10.1016/j.neurobiolaging.2011.03.014
Gabelle A, Jaussent I, Hirtz C, Vialaret J, Navucet S, Grasselli C, Robert P, Lehmann S, Dauvilliers Y (2017) Cerebrospinal fluid levels of orexin-A and histamine, and sleep profile within the Alzheimer process. Neurobiology of aging 53:59-66. doi:10.1016/j.neurobiolaging.2017.01.011
Hagan JJ, Leslie RA, Patel S, Evans ML, Wattam TA, Holmes S, Benham CD, Taylor SG, Routledge C, Hemmati P, Munton RP, Ashmeade TE, Shah AS, Hatcher JP, Hatcher PD, Jones DN, Smith MI, Piper DC, Hunter AJ, Porter RA, Upton N (1999) Orexin A activates locus coeruleus cell firing and increases arousal in the rat. Proceedings of the National Academy of Sciences of the United States of America 96 (19):10911-10916. doi:10.1073/pnas.96.19.10911
Hamuro A, Honda M, Wakaura Y (2018) Suvorexant for the treatment of insomnia in patients with Alzheimer's disease. The Australian and New Zealand journal of psychiatry 52 (2):207-208. doi:10.1177/0004867417747402
Harris GC, Aston-Jones G (2006) Arousal and reward: a dichotomy in orexin function. Trends in neurosciences 29 (10):571-577. doi:10.1016/j.tins.2006.08.002
Harris GC, Wimmer M, Aston-Jones G (2005) A role for lateral hypothalamic orexin neurons in reward seeking. Nature 437 (7058):556-559. doi:10.1038/nature04071
Iyer M, Essner RA, Klingenberg B, Carter ME (2018) Identification of discrete, intermingled hypocretin neuronal populations. The Journal of comparative neurology 526 (18):2937-2954. doi:10.1002/cne.24490
Joo JY, Schaukowitch K, Farbiak L, Kilaru G, Kim TK (2016) Stimulus-specific combinatorial functionality of neuronal c-fos enhancers. Nature neuroscience 19 (1):75-83. doi:10.1038/nn.4170
Kang JE, Lim MM, Bateman RJ, Lee JJ, Smyth LP, Cirrito JR, Fujiki N, Nishino S, Holtzman DM (2009) Amyloid-beta dynamics are regulated by orexin and the sleep-wake cycle. Science 326 (5955):1005-1007. doi:10.1126/science.1180962
Kent BA, Strittmatter SM, Nygaard HB (2018) Sleep and EEG Power Spectral Analysis in Three Transgenic Mouse Models of Alzheimer's Disease: APP/PS1, 3xTgAD, and Tg2576. Journal of Alzheimer's disease : JAD 64 (4):1325-1336. doi:10.3233/JAD-180260
Kukkonen JP, Holmqvist T, Ammoun S, Akerman KE (2002) Functions of the orexinergic/hypocretinergic system. American journal of physiology Cell physiology 283 (6):C1567-1591. doi:10.1152/ajpcell.00055.2002
Lee MG, Hassani OK, Jones BE (2005) Discharge of identified orexin/hypocretin neurons across the sleep-waking cycle. The Journal of neuroscience : the official journal of the Society for Neuroscience 25 (28):6716-6720. doi:10.1523/JNEUROSCI.1887-05.2005
Li SB, de Lecea L (2020) The hypocretin (orexin) system: from a neural circuitry perspective. Neuropharmacology 167:107993. doi:10.1016/j.neuropharm.2020.107993
Liguori C, Nuccetelli M, Izzi F, Sancesario G, Romigi A, Martorana A, Amoroso C, Bernardini S, Marciani MG, Mercuri NB, Placidi F (2016) Rapid eye movement sleep disruption and sleep fragmentation are associated with increased orexin-A cerebrospinal-fluid levels in mild cognitive impairment due to Alzheimer's disease. Neurobiology of aging 40:120-126. doi:10.1016/j.neurobiolaging.2016.01.007
Liguori C, Romigi A, Nuccetelli M, Zannino S, Sancesario G, Martorana A, Albanese M, Mercuri NB, Izzi F, Bernardini S, Nitti A, Sancesario GM, Sica F, Marciani MG, Placidi F (2014) Orexinergic system dysregulation, sleep impairment, and cognitive decline in Alzheimer disease. JAMA neurology 71 (12):1498-1505. doi:10.1001/jamaneurol.2014.2510
Liguori C, Spanetta M, Izzi F, Franchini F, Nuccetelli M, Sancesario GM, Di Santo S, Bernardini S, Mercuri NB, Placidi F (2020) Sleep-Wake Cycle in Alzheimer's Disease Is Associated with Tau Pathology and Orexin Dysregulation. Journal of Alzheimer's disease : JAD 74 (2):501-508. doi:10.3233/JAD-191124
Lim MM, Gerstner JR, Holtzman DM (2014) The sleep-wake cycle and Alzheimer's disease: what do we know? Neurodegenerative disease management 4 (5):351-362. doi:10.2217/nmt.14.33
Luna SL, Brown DI, Eghlidi DH, Kohama SG, Urbanski HF (2017) Locomotor activity and the expression of orexin A and orexin B in aged female rhesus macaques. Neurobiology of aging 50:1-4. doi:10.1016/j.neurobiolaging.2016.10.016
Makela KA, Wigren HK, Zant JC, Sakurai T, Alhonen L, Kostin A, Porkka-Heiskanen T, Herzig KH (2010) Characterization of sleep-wake patterns in a novel transgenic mouse line overexpressing human prepro-orexin/hypocretin. Acta physiologica 198 (3):237-249. doi:10.1111/j.1748-1716.2009.02068.x
Mander BA, Winer JR, Jagust WJ, Walker MP (2016) Sleep: A Novel Mechanistic Pathway, Biomarker, and Treatment Target in the Pathology of Alzheimer's Disease? Trends in neurosciences 39 (8):552-566. doi:10.1016/j.tins.2016.05.002
Peyron C, Tighe DK, van den Pol AN, de Lecea L, Heller HC, Sutcliffe JG, Kilduff TS (1998) Neurons containing hypocretin (orexin) project to multiple neuronal systems. The Journal of neuroscience : the official journal of the Society for Neuroscience 18 (23):9996-10015
Platt B, Drever B, Koss D, Stoppelkamp S, Jyoti A, Plano A, Utan A, Merrick G, Ryan D, Melis V, Wan H, Mingarelli M, Porcu E, Scrocchi L, Welch A, Riedel G (2011) Abnormal cognition, sleep, EEG and brain metabolism in a novel knock-in Alzheimer mouse, PLB1. PloS one 6 (11):e27068. doi:10.1371/journal.pone.0027068
Roh JH, Huang Y, Bero AW, Kasten T, Stewart FR, Bateman RJ, Holtzman DM (2012) Disruption of the sleep-wake cycle and diurnal fluctuation of beta-amyloid in mice with Alzheimer's disease pathology. Science translational medicine 4 (150):150ra122. doi:10.1126/scitranslmed.3004291
Roth T, Brunton S (2019) Identification and Management of Insomnia in Alzheimer's Disease. The Journal of family practice 68 (8):S32-S38
Thal DR, Ronisz A, Tousseyn T, Rijal Upadhaya A, Balakrishnan K, Vandenberghe R, Vandenbulcke M, von Arnim CAF, Otto M, Beach TG, Lilja J, Heurling K, Chakrabarty A, Ismail A, Buckley C, Smith APL, Kumar S, Farrar G, Walter J (2019) Different aspects of Alzheimer's disease-related amyloid beta-peptide pathology and their relationship to amyloid positron emission tomography imaging and dementia. Acta neuropathologica communications 7 (1):178. doi:10.1186/s40478-019-0837-9
Tsuneki H, Wada T, Sasaoka T (2010) Role of orexin in the regulation of glucose homeostasis. Acta physiologica 198 (3):335-348. doi:10.1111/j.1748-1716.2009.02008.x
Um YH, Lim HK (2020) Orexin and Alzheimer's Disease: A New Perspective. Psychiatry investigation. doi:10.30773/pi.2020.0136
Vanderheyden WM, Lim MM, Musiek ES, Gerstner JR (2018) Alzheimer's Disease and Sleep-Wake Disturbances: Amyloid, Astrocytes, and Animal Models. The Journal of neuroscience : the official journal of the Society for Neuroscience 38 (12):2901-2910. doi:10.1523/JNEUROSCI.1135-17.2017
Varga AW, Wohlleber ME, Gimenez S, Romero S, Alonso JF, Ducca EL, Kam K, Lewis C, Tanzi EB, Tweardy S, Kishi A, Parekh A, Fischer E, Gumb T, Alcolea D, Fortea J, Lleo A, Blennow K, Zetterberg H, Mosconi L, Glodzik L, Pirraglia E, Burschtin OE, de Leon MJ, Rapoport DM, Lu SE, Ayappa I, Osorio RS (2016) Reduced Slow-Wave Sleep Is Associated with High Cerebrospinal Fluid Abeta42 Levels in Cognitively Normal Elderly. Sleep 39 (11):2041-2048. doi:10.5665/sleep.6240
Vitiello MV, Prinz PN (1989) Alzheimer's disease. Sleep and sleep/wake patterns. Clinics in geriatric medicine 5 (2):289-299
Weng YY, Lei X, Yu J (2020) Sleep spindle abnormalities related to Alzheimer's disease: a systematic mini-review. Sleep medicine 75:37-44. doi:10.1016/j.sleep.2020.07.044
Wennstrom M, Londos E, Minthon L, Nielsen HM (2012) Altered CSF orexin and alpha-synuclein levels in dementia patients. Journal of Alzheimer's disease : JAD 29 (1):125-132. doi:10.3233/JAD-2012-111655
Willie JT, Takahira H, Shibahara M, Hara J, Nomiyama M, Yanagisawa M, Sakurai T (2011) Ectopic overexpression of orexin alters sleep/wakefulness states and muscle tone regulation during REM sleep in mice. Journal of molecular neuroscience : MN 43 (2):155-161. doi:10.1007/s12031-010-9437-7
Zhang F, Zhong R, Li S, Fu Z, Wang R, Wang T, Huang Z, Le W (2019a) Alteration in sleep architecture and electroencephalogram as an early sign of Alzheimer's disease preceding the disease pathology and cognitive decline. Alzheimer's & dementia : the journal of the Alzheimer's Association 15 (4):590-597. doi:10.1016/j.jalz.2018.12.004
Zhang P, Kishimoto Y, Grammatikakis I, Gottimukkala K, Cutler RG, Zhang S, Abdelmohsen K, Bohr VA, Misra Sen J, Gorospe M, Mattson MP (2019b) Senolytic therapy alleviates Abeta-associated oligodendrocyte progenitor cell senescence and cognitive deficits in an Alzheimer's disease model. Nature neuroscience 22 (5):719-728. doi:10.1038/s41593-019-0372-9
Zheng M, Liu J, Ruan Z, Tian S, Ma Y, Zhu J, Li G (2013) Intrahippocampal injection of Abeta1-42 inhibits neurogenesis and down-regulates IFN-gamma and NF-kappaB expression in hippocampus of adult mouse brain. Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis 20 (1):13-20. doi:10.3109/13506129.2012.755122
Zhurakovskaya E, Ishchenko I, Gureviciene I, Aliev R, Grohn O, Tanila H (2019) Impaired hippocampal-cortical coupling but preserved local synchrony during sleep in APP/PS1 mice modeling Alzheimer's disease. Scientific reports 9 (1):5380. doi:10.1038/s41598-019-41851-5